Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095362233> ?p ?o ?g. }
- W2095362233 endingPage "597" @default.
- W2095362233 startingPage "586" @default.
- W2095362233 abstract "The objective of this study was to develop poly(lactic-co-glycolic acid) (PLGA) injectable implants (i.e., millicylinders) with microencapsulated N-acetylcysteine (NAC) for site-specific controlled NAC release, for potential chemopreventive applications in persons with previously excised head and neck cancers. PLGA 50:50 (i.v. = 0.57 dl/g) implants with 1–10 wt% NAC free acid or 10 wt% NAC salts (NAC–Na+, NAC–Mg2+ and NAC–Ca2+) were prepared by solvent extrusion and/or fluid energy micronization (FEM) methods. X-ray diffraction (XRD), scanning electron microscopy (SEM), and differential scanning calorimetry (DSC) studies were performed to evaluate the physical mixing of NAC with PLGA. PLGA implant degradation was studied by kinetics of polymer molecular weight decline (gel permeation chromatography) and mass loss. Release studies were conducted in N2 purged PBS (pH 7.4) at 37°C in evacuated and sealed ampoules. NAC was quantified by HPLC at 210 nm. XRD, SEM and DSC studies indicated that NAC had dissolved in the polymer phase at 1–3.5% w/w loading, but became discretely suspended in the polymer at 6–10% w/w. Initial burst and long-term release rate increased with increased drug loading, and release was uncharacteristically rapid at higher loading (6–10% w/w). The cause of the rapid release was linked to extensive plasticization, matrix porosity and general acid catalysis of PLGA degradation caused by the NAC free acid. PLGA millicylinders loaded with 10% w/w NAC–Ca2+ and NAC–Mg2+salts exhibited reduced burst (34 vs 13–22% release within a day of incubation for NAC free acid vs NAC–Ca2+ and NAC–Mg2+salts, respectively) and slow and continuous complete release over 4 weeks without significant NAC-catalyzed degradation of PLGA. Release of NAC from NAC–Ca2+/PLGA implant was slower than that of NAC–Mg2+/PLGA consistent with the lower solubility of the former salt. NAC with its free thiol was rapidly converted to its cystine dimer in the presence of molecular oxygen. PLGA released samples in sealed and evacuated ampoules indicated >80% parent NAC remaining after the 1 month release analysis irrespective of initial NAC free acid and salt forms. By encapsulating the NAC–Mg2+ and NAC–Ca2+ salts in PLGA implants, the high initial burst, short release duration, and the general acid catalysis caused by the NAC free acid were each prevented and 1-month slow and continuous release was attained with minimal instability of the free thiol group." @default.
- W2095362233 created "2016-06-24" @default.
- W2095362233 creator A5042191575 @default.
- W2095362233 creator A5050669985 @default.
- W2095362233 creator A5086348397 @default.
- W2095362233 date "2007-09-22" @default.
- W2095362233 modified "2023-10-14" @default.
- W2095362233 title "Formulation and Characterization of Injectable Poly(dl-lactide-co-glycolide) Implants Loaded with N-Acetylcysteine, a MMP Inhibitor" @default.
- W2095362233 cites W1551030049 @default.
- W2095362233 cites W1800142641 @default.
- W2095362233 cites W1965734230 @default.
- W2095362233 cites W196625813 @default.
- W2095362233 cites W1967847250 @default.
- W2095362233 cites W1972393042 @default.
- W2095362233 cites W1976414226 @default.
- W2095362233 cites W1978034836 @default.
- W2095362233 cites W1983609115 @default.
- W2095362233 cites W1984054252 @default.
- W2095362233 cites W1996787559 @default.
- W2095362233 cites W2018793316 @default.
- W2095362233 cites W2024007859 @default.
- W2095362233 cites W2031993236 @default.
- W2095362233 cites W2035817557 @default.
- W2095362233 cites W2039207014 @default.
- W2095362233 cites W2054108381 @default.
- W2095362233 cites W2057959903 @default.
- W2095362233 cites W2070303120 @default.
- W2095362233 cites W2072477273 @default.
- W2095362233 cites W2076587760 @default.
- W2095362233 cites W2098849012 @default.
- W2095362233 cites W2157026406 @default.
- W2095362233 cites W2403063138 @default.
- W2095362233 cites W2412593797 @default.
- W2095362233 cites W2419028619 @default.
- W2095362233 cites W2524143146 @default.
- W2095362233 cites W4235935036 @default.
- W2095362233 doi "https://doi.org/10.1007/s11095-007-9430-1" @default.
- W2095362233 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2405913" @default.
- W2095362233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17891553" @default.
- W2095362233 hasPublicationYear "2007" @default.
- W2095362233 type Work @default.
- W2095362233 sameAs 2095362233 @default.
- W2095362233 citedByCount "31" @default.
- W2095362233 countsByYear W20953622332012 @default.
- W2095362233 countsByYear W20953622332013 @default.
- W2095362233 countsByYear W20953622332014 @default.
- W2095362233 countsByYear W20953622332016 @default.
- W2095362233 countsByYear W20953622332017 @default.
- W2095362233 countsByYear W20953622332018 @default.
- W2095362233 countsByYear W20953622332019 @default.
- W2095362233 countsByYear W20953622332020 @default.
- W2095362233 countsByYear W20953622332022 @default.
- W2095362233 countsByYear W20953622332023 @default.
- W2095362233 crossrefType "journal-article" @default.
- W2095362233 hasAuthorship W2095362233A5042191575 @default.
- W2095362233 hasAuthorship W2095362233A5050669985 @default.
- W2095362233 hasAuthorship W2095362233A5086348397 @default.
- W2095362233 hasBestOaLocation W20953622332 @default.
- W2095362233 hasConcept C121332964 @default.
- W2095362233 hasConcept C13965031 @default.
- W2095362233 hasConcept C155672457 @default.
- W2095362233 hasConcept C171250308 @default.
- W2095362233 hasConcept C185592680 @default.
- W2095362233 hasConcept C192562407 @default.
- W2095362233 hasConcept C2780165375 @default.
- W2095362233 hasConcept C39519442 @default.
- W2095362233 hasConcept C43617362 @default.
- W2095362233 hasConcept C97355855 @default.
- W2095362233 hasConceptScore W2095362233C121332964 @default.
- W2095362233 hasConceptScore W2095362233C13965031 @default.
- W2095362233 hasConceptScore W2095362233C155672457 @default.
- W2095362233 hasConceptScore W2095362233C171250308 @default.
- W2095362233 hasConceptScore W2095362233C185592680 @default.
- W2095362233 hasConceptScore W2095362233C192562407 @default.
- W2095362233 hasConceptScore W2095362233C2780165375 @default.
- W2095362233 hasConceptScore W2095362233C39519442 @default.
- W2095362233 hasConceptScore W2095362233C43617362 @default.
- W2095362233 hasConceptScore W2095362233C97355855 @default.
- W2095362233 hasIssue "3" @default.
- W2095362233 hasLocation W20953622331 @default.
- W2095362233 hasLocation W20953622332 @default.
- W2095362233 hasLocation W20953622333 @default.
- W2095362233 hasLocation W20953622334 @default.
- W2095362233 hasOpenAccess W2095362233 @default.
- W2095362233 hasPrimaryLocation W20953622331 @default.
- W2095362233 hasRelatedWork W2008307937 @default.
- W2095362233 hasRelatedWork W2016889033 @default.
- W2095362233 hasRelatedWork W2024047287 @default.
- W2095362233 hasRelatedWork W2027227296 @default.
- W2095362233 hasRelatedWork W2073411708 @default.
- W2095362233 hasRelatedWork W2107680748 @default.
- W2095362233 hasRelatedWork W2120319941 @default.
- W2095362233 hasRelatedWork W2369675345 @default.
- W2095362233 hasRelatedWork W2899084033 @default.
- W2095362233 hasRelatedWork W4385784439 @default.
- W2095362233 hasVolume "25" @default.
- W2095362233 isParatext "false" @default.
- W2095362233 isRetracted "false" @default.